Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24206099 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
Conditions: Attention Deficit Hyperactivity Disorder;   Dyslexia
Interventions: Drug: Atomoxetine;   Drug: Placebo

Indicates status has not been verified in more than two years